[Dose-response relationship in radiotherapy: an evidence?].

Area of Science:

• Radiobiology and Radiation Oncology
• Clinical Cancer Research

Background:

• The dose-response relationship is a cornerstone of radiobiology.
• Clinical data often show difficulties in linking radiation dose to local tumor control.
• Factors like combined treatments, tumor heterogeneity, and study limitations complicate analysis.

Purpose of the Study:

• To discuss the dose-response relationship in various tumor types.
• To evaluate the impact of radiation dose on local control across different clinical scenarios.
• To highlight the role of dose-response in guiding future radiation therapy research.

Main Methods:

• Review and discussion of clinical data, including retrospective studies and prospective randomized trials.
• Analysis of dose-response relationships in specific tumor sites: breast, soft tissue sarcomas, prostate, lung, esophageal, head and neck, and hepatocellular carcinoma.
• Consideration of advanced techniques like conformal radiotherapy and combined treatment modalities.

Main Results:

• Dose-response is clearly demonstrated in tumors with high local control probability (e.g., breast cancer, soft tissue sarcomas).
• Dose-response appears significant for intermediate control probability tumors (e.g., prostate cancer) based on ongoing trials.
• For low control probability tumors (e.g., lung, esophageal), dose escalation may offer modest benefits compared to concurrent chemotherapy.

Conclusions:

• The dose-response relationship remains a fundamental principle in radiation therapy for many cancers.
• Its importance varies significantly depending on the tumor type and its biological characteristics.
• Understanding dose-response is critical for designing effective future clinical trials and optimizing radiation oncology practice.